EPHA5 (EPH receptor A5)

2003-02-01  

Identity

HGNC
LOCATION
4q13.1
LOCUSID
ALIAS
CEK7,EHK-1,EHK1,EK7,HEK7,TYRO4
FUSION GENES

Other Information

Locus ID:

NCBI: 2044
MIM: 600004
HGNC: 3389
Ensembl: ENSG00000145242

Variants:

dbSNP: 2044
ClinVar: 2044
TCGA: ENSG00000145242
COSMIC: EPHA5

RNA/Proteins

Gene IDTranscript IDUniprot
ENSG00000145242ENST00000273854P54756
ENSG00000145242ENST00000273854A0A384MU00
ENSG00000145242ENST00000354839P54756
ENSG00000145242ENST00000432638F8W9W0
ENSG00000145242ENST00000511294F8VP57
ENSG00000145242ENST00000613740B7ZKW7
ENSG00000145242ENST00000622150B7ZKJ3

Expression (GTEx)

0
1
2
3
4
5
6

Pathways

PathwaySourceExternal ID
Axon guidanceKEGGko04360
Axon guidanceKEGGhsa04360
Developmental BiologyREACTOMER-HSA-1266738
Axon guidanceREACTOMER-HSA-422475
EPH-Ephrin signalingREACTOMER-HSA-2682334
EPHA-mediated growth cone collapseREACTOMER-HSA-3928663
EPH-ephrin mediated repulsion of cellsREACTOMER-HSA-3928665

PharmGKB

Entity IDNameTypeEvidenceAssociationPKPDPMIDs
PA443560Breast NeoplasmsDiseaseClinicalAnnotationassociatedPD22843789, 26133776, 26133777, 26763541
PA445204Ovarian NeoplasmsDiseaseClinicalAnnotationassociatedPD22843789, 26133776, 26133777, 26763541
PA450761paclitaxelChemicalClinicalAnnotationassociatedPD22843789, 26133776, 26133777, 26763541

References

Pubmed IDYearTitleCitations
353325882022Expression of EPHA5 in lung adenocarcinoma is associated with lymph node metastasis and EGFR mutation.2
361646082022Association between EPHA5 methylation status in peripheral blood leukocytes and the risk and prognosis of gastric cancer.1
363459522022Immunohistochemical evaluation of forkhead box A1 and EphA5 markers in serous ovarian carcinomas, and their impact on the clinical outcome of patients.1
353325882022Expression of EPHA5 in lung adenocarcinoma is associated with lymph node metastasis and EGFR mutation.2
361646082022Association between EPHA5 methylation status in peripheral blood leukocytes and the risk and prognosis of gastric cancer.1
363459522022Immunohistochemical evaluation of forkhead box A1 and EphA5 markers in serous ovarian carcinomas, and their impact on the clinical outcome of patients.1
341093822021Deep learning model reveals potential risk genes for ADHD, especially Ephrin receptor gene EPHA5.5
341093822021Deep learning model reveals potential risk genes for ADHD, especially Ephrin receptor gene EPHA5.5
318233782020Genetic variation in EPHA contributes to sensitivity to paclitaxel-induced peripheral neuropathy.9
322343412020EPHA5 mutation impairs natural killer cell-mediated cytotoxicity against non-small lung cancer cells and promotes cancer cell migration and invasion.6
332887382020EPHA5 mutations predict survival after immunotherapy in lung adenocarcinoma.12
318233782020Genetic variation in EPHA contributes to sensitivity to paclitaxel-induced peripheral neuropathy.9
322343412020EPHA5 mutation impairs natural killer cell-mediated cytotoxicity against non-small lung cancer cells and promotes cancer cell migration and invasion.6
332887382020EPHA5 mutations predict survival after immunotherapy in lung adenocarcinoma.12
275824842017Targeted Sequencing Reveals Low-Frequency Variants in EPHA Genes as Markers of Paclitaxel-Induced Peripheral Neuropathy.9

Citation

Dessen P

EPHA5 (EPH receptor A5)

Atlas Genet Cytogenet Oncol Haematol. 2003-02-01

Online version: http://atlasgeneticsoncology.org/gene/40465/epha5-(eph-receptor-a5)